Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Siu, S.S.N.
Right arrow Articles by Lau, T.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siu, S.S.N.
Right arrow Articles by Lau, T.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 11, 2423-2425, November 2000
© 2000 European Society of Human Reproduction and Embryology

A study on placental transfer of diclofenac in first trimester of human pregnancy

S.S.N. Siu1,4, J.H.K. Yeung2 and T.K. Lau3

1 Department of Obstetrics and Gynaecology, Prince of Wales Hospital, 2 Department of Pharmacology and 3 Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong

Diclofenac is a commonly used non-steroidal anti-inflammatory drug in women of reproductive age. It has teratogenic effects in animals. The aim of this study was to investigate the placental transfer of diclofenac in the first trimester of human pregnancy. Thirty patients undergoing surgical termination of pregnancy between 8 and 12 weeks gestation were given two doses of diclofenac before the procedure. Corresponding samples of maternal serum, amniotic fluid, coelomic fluid and fetal tissue were analysed by high-performance liquid chromatography. Diclofenac was detectable in all fetal tissue samples, with a concentration similar to that found in maternal venous samples. However, diclofenac was detectable in only 56.7 and 23.3% of the coelomic and amniotic fluid samples respectively, and the highest concentration attained was 80 and 5% of the maternal concentration respectively. In summary, we confirmed that diclofenac crosses the human placenta readily during the first trimester. Further studies are required to investigate the potential teratogenic effect of diclofenac in human embryos.

Key words: diclofenac/human/placental transfer/pregnancy/teratogenicity

4 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Shatin, Hong Kong. E-mail: nelsonsiu{at}cuhk.edu.hk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
S.S.N. Siu, J.H.K. Yeung, and T.K. Lau
An in-vivo study on placental transfer of naproxen in early human pregnancy
Hum. Reprod., April 1, 2002; 17(4): 1056 - 1059.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.